Big pharma braces for revenue headwinds as patent expiries loom
More than half of the top 15 pharma companies are expected to face challenges in managing the patent cliff.
Brii Biosciences and Joincare sign licence agreement for BRII-693
BioVersys and Shionogi agree to develop ansamycin leads
UK Government reveals 10-year plan for NHS
Regeneron nabs dosing edge with Lynozyfic’s FDA approval in multiple myeloma
Merck concludes SpringWorks acquisition for $3.4bn
Analysis
View More
Themes
View MoreFive lessons from biopharma companies’ data transformation journeys
A sales rep looking up a healthcare professional's (HCP) contact details finds three records, each with conflicting information. At the same time, leadership struggles to generate accurate global reports due...
More themes
Data Insights
View MoreCell & gene therapy: the leading companies in recombinant AAV gene therapy revealed
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
Digital health and digital therapeutics (DTx) services and providers for the pharmaceutical industry
GlobalData Reports
View More
Digital Magazine
View MorePharma Technology Focus
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Lisata collaborates with GATC Health on drug development
Juvenescence enhances AI drug discovery with Ro5 acquisition
Pharma’s AI prospects get nudged into the future with EU’s AI act
Next-generation targeting for evolving HCP engagement